3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin has been researched along with Leukemia L 1210 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Acton, EM; Mosher, CW; Tong, GL; Wolgemuth, RL | 1 |
Courseille, C; Dautant, A; Langlois D'estaintot, B; Mondon, M; Précigoux, G; Saminadin, P | 1 |
Groth, G; Marquardt, H; Steinheider, G; Westendorf, J | 1 |
3 other study(ies) available for 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and Leukemia L 1210
Article | Year |
---|---|
Intensely potent morpholinyl anthracyclines.
Topics: Animals; Antibiotics, Antineoplastic; Doxorubicin; Drug Evaluation, Preclinical; Indicators and Reagents; Leukemia L1210; Leukemia P388; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Structure-Activity Relationship | 1984 |
Release of the cyano moiety in the crystal structure of N-cyanomethyl-N-(2-methoxyethyl)-daunomycin complexed with d(CGATCG).
Topics: Animals; Antibiotics, Antineoplastic; Crystallography, X-Ray; Cyanides; Daunorubicin; DNA; Doxorubicin; Inhibitory Concentration 50; Leukemia L1210; Models, Molecular; Nucleic Acid Conformation | 2000 |
Formation of DNA-adducts and induction of DNA-crosslinks and chromosomal aberrations by the new potent anthracycline antitumor antibiotics: morpholinodaunomycin, cyanomorpholinodaunomycin and cyanomorpholinoadriamycin.
Topics: Animals; Antibiotics, Antineoplastic; Cells, Cultured; Chemical Phenomena; Chemistry; Chromosome Aberrations; Daunorubicin; DNA; DNA Repair; Doxorubicin; Leukemia L1210; Liver; Rats | 1985 |